C

롤링스톤

214610KOSDAQ의료용 기기 제조업

43.0 / 100

Reference Date: 2026-04-13

Financial Score20.5 / 40
News Sentiment12.5 / 25
Momentum3.0 / 20
Disclosure7.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Declined 9.5% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Rolling Stone Co., Ltd., established in 2009, specializes in developing molecular diagnostic equipment and kits based on LabChip technology, holding patents in 17 countries. The company offers solutions for infectious disease diagnosis, A2 milk detection, immuno/biochemical diagnostic products, and is expanding into digital healthcare and fuel trading to diversify its portfolio and achieve sustainable growth.

Number of Employees

16people

Average Salary

54.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 26.524.0Point
PBR
1.20Industry Average 1.705.5Point

Lower than industry avg (good)

ROE
-115.23Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
6.64Industry Average 10.955.0Point

Lower than industry avg (good)

Trend 2023~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲60.5% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲24.5% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -104.4% (declining, 3yr)

Detailed News Sentiment

9 totalPositive 0Neutral 4Negative 0Average Sentiment Score 50

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 2,290Won52-week high 8,47052-week low 2,255
1-month return1.0Point

1m -9.49% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

18 totalPositive 0Neutral 17Negative 1
  • Neutral주권매매거래정지기간변경 (개선기간 부여)2026-04-10
  • Neutral기타시장안내 (상장폐지 관련 이의신청서 접수 및 개선기간 부여)2026-04-10
  • Neutral주주총회소집결의 (임시주주총회)2026-04-06
  • Neutral주주명부폐쇄기간또는기준일설정2026-04-06
  • Neutral주식등의대량보유상황보고서(일반)2026-04-03